BioNTech counts on shift to cancer drugs after second quarter losses quadruple

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to BioNTech counts on shift to cancer drugs after second quarter losses quadruple
(NASDAQ: BNTX) Delayed: 98.66 +2.83 (2.95%)
Previous Close $95.83    52 Week High $ 
Open $97.50    52 Week Low $ 
Day High $99.58    P/E N/A 
Day Low $97.13    EPS $ 
Volume 708,503